Quadient S.A. : Close to a support level
Entry price | Target | Stop-loss | Potential |
---|
€38.1 |
€41.6 |
€36.4 |
+9.19% |
---|
The fact that share price is returning to the lower bounds of the trading range offers a good timing to enter into new long positions in Neopost.
Summary● In a short-term perspective, the company has interesting fundamentals.
Strengths● The company returns high margins, thereby supporting business profitability.
● Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
● Its low valuation, with P/E ratio at 10.38 and 9.63 for the ongoing fiscal year and 2019 respectively, makes the stock pretty attractive with regard to earnings multiples.
● This company will be of major interest to investors in search of a high dividend stock.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● The stock is in a well-established, long-term rising trend above the technical support level at 30.06 EUR
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company is in debt and has limited leeway for investment
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.